Lumateperone is a second-generation atypical antipsychotic compound used as an active pharmaceutical ingredient. It has a unique receptor binding profile that modulates glutamate, serotonin, and dopamine neurotransmitters, and is associated with a favorable adverse effect profile compared to other antipsychotics.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 313368-91-1
Lumateperone tosylate
pharmaceutical raw material
Dexlansoprazole sesquihydrate
pharmaceutical raw material
Calcium pidolate
pharmaceutical raw material
Apomorphine hydrochloride
pharmaceutical raw material
Flubendazole
pharmaceutical raw material
Lumateperone Impurity 1
pharmaceutical raw material
1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one
HOIIHACBCFLJET-SFTDATJTSA-N
CN1CCN2[C@H]3CCN(C[C@H]3C4=C2C1=CC=C4)CCCC(=O)C5=CC=C(C=C5)F